Physician profile
Hannah Manning
NPI 1780378521
$14,457.30
in general payments reported to CMS, 2019-2025
74 companies · $7,670 in 2025
The $7,670 reported for 2025 was more than what 99% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,862 · 2024: $4,925 · 2025: $7,670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,358.30 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $849.18 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $791.44 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $672.69 | 2023-2025 | Fruzaqla, Alunbrig, Ninlaro |
| Astrazeneca Pharmaceuticals Lp | $656.15 | 2023-2025 | Imfinzi, Enhertu, Lynparza |
| Eisai INC. | $643.88 | 2023-2025 | |
| Incyte Corporation | $632.14 | 2023-2025 | Jakafi, Monjuvi, Pemazyre |
| Bayer Healthcare Pharmaceuticals INC. | $506.46 | 2023-2025 | |
| Karyopharm Therapeutics INC. | $491.55 | 2023-2025 | Xpovio |
| Janssen Biotech, INC. | $489.28 | 2023-2025 | Darzalex, Talvey, Rybrevant |
| Merck Sharp & Dohme LLC | $445.38 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Exelixis INC. | $433.04 | 2023-2025 | Cabometyx |
| Pfizer INC. | $420.93 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $395.75 | 2023-2025 | Libtayo, Lynozyfic |
| Sobi, INC | $383.90 | 2024-2025 | |
| Daiichi Sankyo INC. | $364.83 | 2023-2025 | Enhertu, Vanflyta, Datroway |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $343.32 | 2023-2025 | Ojjaara, Zejula, Jemperli |
| Stemline Therapeutics INC. | $321.25 | 2024-2025 | Orserdu |
| Genentech USA, INC. | $311.62 | 2023-2025 | Tecentriq, Phesgo, Itovebi |
| Puma Biotechnology, INC. | $291.39 | 2023-2025 | Nerlynx |
| Astellas Pharma US INC | $291.03 | 2024-2025 | Xtandi, Vyloy, Padcev |
| E.R. Squibb & Sons, L.L.C. | $249.01 | 2024-2025 | Opdivo, Opdualag |
| Lilly USA, LLC | $239.11 | 2023-2025 | Jaypirca, Verzenio, Retevmo |
| Genmab U.S., INC. | $226.51 | 2023-2025 | Epkinly |
| Gilead Sciences, INC. | $205.90 | 2023-2025 | Trodelvy |
| Pharmaessentia USA Corporation | $193.60 | 2024-2025 | Besremi |
| Genzyme Corporation | $187.41 | 2023-2025 | |
| Beigene USA, INC. | $158.80 | 2023-2025 | Brukinsa |
| Pharmacosmos Therapeutics INC. | $154.73 | 2023-2025 | Monoferric |
| Deciphera Pharmaceuticals INC. | $148.07 | 2023-2025 | Qinlock, Romvimza |
| Ipsen Biopharmaceuticals, INC | $146.58 | 2023-2025 | Onivyde, Somatuline Depot |
| Celgene Corporation | $141.71 | 2024-2025 | Reblozyl, Opdualag |
| Coherus Oncology, INC. | $137.91 | 2023-2025 | Loqtorzi |
| Aveo Pharmaceuticals, INC. | $135.65 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $130.19 | 2024-2025 | |
| Emd Serono, INC. | $122.12 | 2023-2025 | Bavencio |
| Dendreon Pharmaceuticals LLC | $121.38 | 2023-2025 | Provenge |
| Azurity Pharmaceuticals, INC. | $110.31 | 2025 | Danziten |
| Beone Medicines USA, INC. | $107.82 | 2025 | Brukinsa, Tevimbra |
| Caris Mpi, INC. | $106.95 | 2025 | Mi Cancer Seek |
| Taiho Oncology, INC. | $95.75 | 2025 | |
| Servier Pharmaceuticals LLC | $94.73 | 2023-2025 | |
| Tersera Therapeutics LLC | $92.25 | 2025 | Xermelo, Zoladex |
| Blueprint Medicines Corporation | $90.54 | 2023-2024 | Ayvakit |
| Recordati_rare_diseases_inc. | $83.48 | 2024-2025 | Enjaymo, Sylvant |
| Agios Pharmaceuticals, INC. | $81.54 | 2024-2025 | Pyrukynd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.19 | 2023-2025 | Gilotrif |
| Seagen INC. | $74.38 | 2023 | Padcev |
| Apellis Pharmaceuticals, INC. | $65.21 | 2025 | Empaveli |
| Iovance Biotherapeutics, INC. | $64.30 | 2025 | Amtagvi |
| Syndax Pharmaceuticals, INC. | $62.88 | 2025 | |
| Legend Biotech USA INC. | $57.30 | 2024-2025 | Carvykti |
| Immunocore Limited | $56.66 | 2024-2025 | Kimmtrak |
| Ge Healthcare | $56.21 | 2025 | |
| Adaptive Biotechnologies Corporation | $54.68 | 2023-2025 | Clonoseq |
| Alexion Pharmaceuticals, INC. | $47.38 | 2023-2024 | Ultomiris |
| Geron Corporation | $46.36 | 2025 | Rytelo |
| Rigel Pharmaceuticals, INC. | $44.23 | 2025 | Tavalisse, Gavreto, Rezlidhia |
| Adc Therapeutics America, INC. | $44.07 | 2023-2025 | |
| Kyowa Kirin, INC. | $40.79 | 2023-2025 | Poteligeo |
| Boston Scientific Corporation | $33.98 | 2025 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Array Biopharma INC | $32.45 | 2025 | Mektovi, Xalkori, Braftovi |
| Fennec Pharmaceuticals, INC. | $31.03 | 2024 | Pedmark |
| Immunogen, INC. | $27.54 | 2023 | Elahere |
| Nuvation Bio INC. | $26.64 | 2025 | Ibtrozi |
| Acrotech Biopharma INC. | $25.67 | 2025 | Beleodaq |
| Mirati Therapeutics, INC. | $25.35 | 2024 | Krazati |
| Myriad Genetic Laboratories, INC. | $23.91 | 2024 | Myrisk |
| Davol INC. | $23.15 | 2025 | Arista |
| Amgen INC. | $22.90 | 2023 | Kyprolis, Blincyto |
| Pharmacyclics LLC, An Abbvie Company | $22.42 | 2023 | Imbruvica, Epkinly |
| Sun Pharmaceutical Industries INC. | $22.11 | 2024 | |
| Novocure INC. | $19.00 | 2025 | Optune Lua (Novottf-200t) |
| Chiesi USA, INC. | $17.08 | 2025 | Ferriprox |
| Emmaus Medical, INC. | $12.17 | 2024 | Endari |
Drugs and devices associated with these payments
Lenvima $644Epkinly $519Xpovio $492Jakafi $451Keytruda $445Nubeqa $400Imbruvica $399Enhertu $374Libtayo $367Padcev $338Cabometyx $334Orserdu $321Imfinzi $274Fruzaqla $266Ojjaara $262Brukinsa $242Jaypirca $239Verzenio $239Elahere $236Alunbrig $227Monjuvi $201Fabhalta $200Besremi $194Darzalex $189Venclexta $180Welireg $165Tecentriq $162Doptelet $160Monoferric $155Xtandi $153Mekinist $153Sarclisa $152Opdualag $150Qinlock $148Somatuline Depot $147Onivyde $147Opdivo $145Talvey $138Rybrevant $136Fotivda $136Vonjo $134Scemblix $134Kisqali $126Pluvicto $126Pemazyre $123Provenge $121Ubrelvy $114Loqtorzi $112Tecvayli $111Danziten $110Mi Cancer Seek $107Vitrakvi $106Stivarga $106Retevmo $106Ninlaro $103Ibrance $101Tukysa $101Zepzelca $99.93Romvimza $99.09Lynparza $97.98Nerlynx $97.82Lonsurf $95.75Inqovi $95.75Reblozyl $95.22Vanflyta $92.39Ayvakit $90.54Synagis $89.68Vyloy $85.37Pyrukynd $81.54Elrexfio $80.72Adcetris $80.72Zynyz $78.57Tibsovo $74.14Enjaymo $67.27Inlyta $65.96Empaveli $65.21Amtagvi $64.30Datroway $59.19Kimmtrak $56.66Trodelvy $55.80Xermelo $55.33Clonoseq $54.68Itovebi $53.87Phesgo $53.87Iclusig $52.67Ultomiris $47.38Rytelo $46.36Gavreto $44.23Tavalisse $44.23Rezlidhia $44.23Poteligeo $40.79Carvykti $40.59Zoladex $36.92Erleada $36.55Xofigo $36.50Tecentriq Hybreza $34.27Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) $33.98Lorbrena $32.45Braftovi $32.45Mektovi $32.45
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Manning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.